DEA Permanent Telehealth Controlled Substance Prescribing Rules Remain Pending Amidst Virginia Drug Control Act Definitions
Last updated 2026-08-20 · Source: law.lis.virginia.gov
The U.S. Drug Enforcement Administration (DEA) has yet to finalize its permanent rules for prescribing controlled substances via telemedicine, despite extending temporary flexibilities. In Virginia, practitioners must continue to adhere to the existing framework outlined in the Virginia Drug Control Act, which provides critical definitions for drug handling and administration within the Commonwealth.
What this means for your practice
For telehealth brands, medspas, dental practices, chiropractic offices, and other healthcare businesses operating in Virginia, the continued pending status of federal DEA telehealth rules means that state-level regulatory adherence remains paramount. Understanding the nuanced definitions within the Virginia Drug Control Act, such as 'administer' and 'compounding,' is crucial for maintaining compliance, especially when dealing with controlled substances. Practices must ensure their protocols for prescription, dispensing, and administration align with these established state definitions, as they are the current legal backbone for drug control within Virginia, regardless of whether care is delivered in-person or via telemedicine. This highlights the importance of maintaining robust compliance programs that track both federal developments and existing state-specific mandates.
Overview of the Regulatory Landscape
The landscape surrounding telehealth prescribing of controlled substances continues to evolve, with significant federal rules from the U.S. Drug Enforcement Administration (DEA) still awaiting finalization. While the DEA has provided temporary extensions for telehealth flexibilities that were initially introduced during the public health emergency, the agency's efforts to establish a permanent regulatory framework for prescribing controlled substances via telemedicine are still ongoing. This means that definitive, long-term federal rules are not yet in force, leaving practitioners and healthcare organizations to navigate a complex regulatory environment that necessitates close attention to existing state statutes.
In this context of federal uncertainty, state-specific legislation, such as the Virginia Drug Control Act, plays a critical role in governing how drugs, including controlled substances, are handled within the Commonwealth. Healthcare businesses operating in Virginia must therefore ensure their practices align with these established state definitions and requirements.
The Virginia Drug Control Act: Foundational Definitions
The Virginia Drug Control Act, codified under § 54.1-3400 et seq. of the Code of Virginia, serves as the comprehensive legal framework for drug control within the state. This chapter outlines essential definitions that govern various aspects of drug handling, from administration and advertising to compounding and ownership changes. Understanding these definitions is fundamental for any practitioner or entity involved in the prescribing, dispensing, or administering of drugs in Virginia.
Key Definitions from § 54.1-3401:
- Administer: This term is precisely defined as the direct application of a controlled substance to the body of a patient or research subject. This can occur either by (i) a practitioner or their authorized agent under the practitioner's direction, or (ii) by the patient or research subject themselves at the direction and in the presence of the practitioner. For telehealth practices, this definition is critical as it delineates the scope of a practitioner's responsibility when guiding patients through self-administration or when an agent is involved in the process.
- Advertisement: The Act defines
Key Facts
| Detail | Value | |---|---| | DEA Permanent Rules Status | Permanent telehealth controlled substance prescribing rules remain pending; temporary flexibilities extended. | | Virginia Legislation Citation | Code of Virginia, Drug Control Act, § 54.1-3400 et seq. | | Purpose of Virginia Act | Establishes definitions for drug control within the Commonwealth. | | Definition of 'Administer' | Direct application of a controlled substance by a practitioner, authorized agent, or patient at practitioner's direction/presence. | | Definition of 'Compounding' | Combining two or more ingredients into a single preparation by a pharmacist or practitioner for a valid prescription, or for research/teaching. |
Frequently Asked Questions
Are the DEA's permanent telehealth prescribing rules for controlled substances finalized?
No, the DEA's permanent rules for prescribing controlled substances via telemedicine are still ongoing and not yet in force, though temporary flexibilities have been extended.
What is 'The Drug Control Act' referenced in Virginia law?
The Drug Control Act is a chapter of the Code of Virginia, cited as § 54.1-3400 et seq., which provides definitions and regulations for drug control within the state.
How does the Virginia Drug Control Act define 'administer' a controlled substance?
It means the direct application of a controlled substance to a patient by a practitioner or their authorized agent under direction, or by the patient at the practitioner's direction and in their presence.
What does 'compounding' entail according to Virginia's Drug Control Act?
Compounding involves combining two or more ingredients into a single preparation by a pharmacist or within a permitted pharmacy for a valid prescription, or by a practitioner as an incident to administering or dispensing, or for research/teaching purposes.
Who is considered an 'agent' under the Virginia Drug Control Act?
An 'agent' is an authorized person who acts on behalf of or at the direction of a manufacturer, distributor, or dispenser, but does not include common carriers, contract carriers, public warehousemen, or their employees.